Orbis Allan Gray LtdOrbis Allan Gray Ltd

Institutional investor · Portfolio as of Q2 2026

Top Holdings97 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

CORPAY INC

5.4M$1.8B6.2%$305.96+33.31%
10 qtrssince 2024-Q1
Increased
63

NEBIUS GROUP N.V.

6.5M$1.8B6.2%$63.88+227.44%
23 qtrssince 2020-Q4
Decreased
0

BOOKING HOLDINGS INC

7.2M$1.3B4.4%$177.95+15.55%
13 qtrssince 2023-Q2
Increased
94

QXO INC

74M$1.3B4.4%
Unchanged
0

BRUKER CORP

17.9M$1.1B3.7%$35.87+59.11%
5 qtrssince 2025-Q2
Unchanged
0

RXO INC

36.4M$1B3.5%$20.55+6.62%
15 qtrssince 2022-Q4
Unchanged
0

MOTOROLA SOLUTIONS INC

2.4M$992.4M3.4%$413.58+17.51%
25 qtrssince 2020-Q2
Increased
73

ALPHABET INC

2.3M$836.5M2.9%$313.85+10.43%
3 qtrssince 2025-Q4
Decreased
0

EQT CORP

15.7M$835.1M2.9%$58.67-6.99%
3 qtrssince 2025-Q4
Increased
69

XPO INC

3.4M$698.6M2.4%$48.71+287.08%
30 qtrssince 2019-Q1
Decreased
0
SHELSHEL
ADR

SHELL PLC

8.8M$686M2.4%$77.19+17.78%
18 qtrssince 2022-Q1
Increased
87

GXO LOGISTICS INCORPORATED

13.4M$680.6M2.3%$58.45-18.56%
20 qtrssince 2021-Q3
Unchanged
0
ITUBITUB
Preferred

ITAU UNIBANCO HLDG S A

81.3M$664.2M2.3%$5.85+28.27%
6 qtrssince 2025-Q1
Increased
63

INSMED INC

6.1M$647.9M2.2%$114.90+3.17%
5 qtrssince 2025-Q2
Increased
87

ALNYLAM PHARMACEUTICALS INC

2M$598.3M2.1%$281.29-15.71%
9 qtrssince 2024-Q2
Increased
74

FIRSTSERVICE CORP NEW

4M$574.7M2.0%$160.55-11.84%
12 qtrssince 2023-Q3
Increased
50

STERIS PLC

2.7M$563.8M1.9%$228.95+2.11%
6 qtrssince 2025-Q1
Increased
51

INTERACTIVE BROKERS GROUP IN

6.1M$528.3M1.8%$41.00+133.77%
19 qtrssince 2021-Q4
Decreased
0

NEWMONT CORP

5.5M$517.8M1.8%$57.51+122.54%
11 qtrssince 2023-Q4
Increased
53

PRAXIS PRECISION MEDICINES I

1.5M$512.2M1.8%$307.46+12.13%
3 qtrssince 2025-Q4
Decreased
0
$29.1B
AUM
97
Positions
Q2 2026
Filing
3.0/5
HI score
Quarterly 13F Value Change
-6%Q1'25$17.5B+18%Q2'25$20.6B+13%Q3'25$23.3B+2%Q4'25$23.9B-1%Q1'26$23.7B+23%Q2'26$29.1B
Activity profile
$ moved · Q2'26
New10%Increased52%Decreased35%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q7%1-4Q24%1-2Y21%2Y+48%

Orbis Allan Gray Ltd manages $29.1B across 97 positions as of Q2 2026. Top holdings: CPAY (6.2%), NBIS (6.2%), BKNG (4.4%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Active quarter - 12 new positions, 6 exits, 45 increased. Top move: BKNG (INCREASED, conviction 94). Portfolio: $29.1B across 97 positions.

Top holdings by portfolio weight

Total AUM$29B
CPAY6.19%
NBIS6.16%
BKNG4.41%
QXO4.39%
BRKR3.71%
RXO3.45%
MSI3.41%
GOOGL2.87%
EQT2.87%
XPO2.40%
Other2.36%

Portfolio allocation by GICS sector

Sectors11
Healthcare16.82%
Industrials15.74%
Communication Services14.62%
Technology12.48%
Energy9.57%
Financial Services8.78%
Consumer Cyclical8.20%
Basic Materials6.47%
Consumer Defensive4.66%
Real Estate2.02%
Other0.63%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Industrials, Communication Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L64
Conviction48
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
FSVFSVFIRSTSERVICE CORP NEW
Q3 2024 Q2 2026+3.8M shares+$533.5M
8Q
MCSMCSMARCUS CORP DEL
Q3 2024 Q2 2026+1.4M shares+$42.6M
8Q
BURBURBURFORD CAPITAL LIMITED
Q3 2024 Q2 2026+8.4M shares-$21.1M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used